Raymond James & Associates’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.66M | Sell |
|
|||||
|
2024
Q2 | $4.64M | Buy |
|
|||||
|
2024
Q1 | $4.25M | Buy |
|
|||||
|
2023
Q4 | $4.1M | Buy |
|
|||||
|
2023
Q3 | $3.3M | Buy |
|
|||||
|
2023
Q2 | $2.85M | Buy |
|
|||||
|
2023
Q1 | $1.97M | Buy |
|
|||||
|
2022
Q4 | $736K | Buy |
|
|||||
|
2022
Q3 | $1.03M | Buy |
|
|||||
|
2022
Q2 | $705K | Sell |
|
|||||
|
2022
Q1 | $1.02M | Sell |
|
|||||
|
2021
Q4 | $2.04M | Sell |
|
|||||
|
2021
Q3 | $3.78M | Buy |
|
|||||
|
2021
Q2 | $3.98M | Sell |
|
|||||
|
2021
Q1 | $2.1M | Buy |
|
|||||
|
2020
Q4 | $998K | Buy |
|
|||||
|
2020
Q3 | $261K | Sell |
|
|||||
|
2020
Q2 | $368K | Sell |
|
|||||
|
2020
Q1 | $228K | Buy |
|
|||||
|
2019
Q4 | $268K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $238K | Sell |
|
|||||
|
2018
Q1 | $264K | Buy |
|